Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of the American Medical Directors Association
- The global prevalence of dementia: A systematic review and metaanalysis.Alzheimers Dement. 2013; 9: 63-75
- Mild cognitive impairment.Arch Neurol. 2009; 66: 1447-1455
- Annual conversion to Alzheimer disease among patients with memory complaints attending an outpatient memory clinic: The influence of amnestic mild cognitive impairment and the predictive value of neuropsychological testing.Wiener Klinische Wochenschrift. 2005; 117: 629-635
- Cholinesterase inhibitors for patients with Alzheimer's disease: Systematic review of randomised clinical trails.BMJ. 2005; 331: 321-327
- The projected effect of risk factor reduction on Alzheimer's disease prevalence.Lancet Neurol. 2011; 10: 819-828
- Brain reserve and the prevention of dementia.Curr Opin Psychiatry. 2008; 21: 296-302
- Exercise: A behavioural intervention to enhance brain health and plasticity.Trends Neurosci. 2002; 25: 295-301
- Endurance and strength training outcomes on cognitively impaired and cognitively intact older adults: A meta-analysis.J Nutr Health Aging. 2008; 12: 401-409
- Brain reserve and cognitive decline: A nonparametric systematic review.Psychol Med. 2006; 36: 1065-1073
- Fitness effects on the cognitive function of older adults: A meta-analytic study.Am Psychol Soc. 2003; 14: 125-130
- The effect of exercise training on cognitive function in older adults with mild cognitive impairment: A meta-analysis of randomized controlled trials.Am J Geriatr Psychiatry. 2013; 21: 1086-1097
- Cognitive and memory training in adults at risk of dementia: A systematic review.BMC Geriatr. 2011; 11: 55
- Exercise builds brain health.Trends Neurosci. 2007; 30: 464-472
- The neurobiology of brain and cognitive reserve: Mental and physical activity as modulators of brain disorders.Prog Neurobiol. 2009; 89: 369-382
- Is there a relationship between fat-free soft tissue mass and low cognitive function? Results from a study of 7105 women.J Am Geriatr Soc. 2002; 50: 1796-1801
- Reduced lean mass in early Alzheimer disease and its association with brain atrophy.Arch Neurol. 2010; 67: 428-433
- Effects of resistance training exercise on cognitive performance in elderly individulas with memory impairment: Results of a controlled trial.Einstein. 2008; 6: 402-407
- Resistance training promotes cognitive and functional brain plasticity in seniors with probable mild cognitive impairment.Arch Neurol. 2012; 172: 666-668
- Study of mental activity and regular training (SMART) in at risk individuals: A randomised double blind, sham controlled, longitudinal trial.BMC Geriatr. 2011; 11: 19
- A new rating scale for Alzheimer's disease.Am J Psychiatry. 1984; 141: 1356-1365
- The bayer activities of daily Living scale (B-ADL).Dement Geriatr Cogn Disord. 1998; 9: 20-26
- Mild cognitive impairment:clinical characterisation and outcome.Arch Neurol. 1999; 56: 303-308
Marker KR. (1986-2008) Marker Software. Heidelberg and Ladenburg.
- A behavioral rehabilitation intervention for amnestic mild cognitive impairment.Am J Alzheimers Dis Other Demen. 2008; 23: 451-461
Wechsler D. Wechsler Memory Scale, 3rd ed. In: Corporation TP, ed. San Diego, CA: Harcourt Brace and Company; 1997.
- Is there a role for physical exercise in preventing decline in people with mild cognitive impairment?.Age Ageing. 2012; 41: 5-8
- Aerobic exercise and neurocognitive performance: A meta-analytic review of randomised controlled trials.Psychosom Med. 2010; 72: 239-252
- Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomized controlled trial.Br J Sports Med. 2008; 42: 344-351
- Effects of aerobic exercise on mild cognitive impairment.Arch Neurol. 2010; 67: 71-79
- Physical activity and executive functions in the elderly with mild cognitive impairment.Aging Mental Health. 2005; 9: 272-280
- Effects of physical activity on cognitive function in older adults at risk for Alzheimer disease.JAMA. 2008; 300: 1027-1037
- Changes in cognitive function in a randomized trial of physical activity: Results of the lifestyle interventions and independence for elders pilot study.J Gerontol Med Sci. 2009; 64A: 688-694
- The effect of group-based exercise on cognitive performance and mood in seniors residing in intermediate care and self-care retirement facilities: A randomised controlled trial.Br J Sports Med. 2009; 43: 608-614
- The influence of short-term strength training on health related quality of life and executive cognitive function.J Physiol Anthropol. 2010; 3: 95-101
- The effects of a three-month exercise programme on neuropsychological function in elderly institutionalized women: a randomized controlled trial.Age Ageing. 1988; 17: 303-310
- The mental activity and eXercise (MAX) trial: A randomized controlled trial to enhance cognitive function in older adults.JAMA Intern Med. 2013; 173: 797-804
- Improvement of cognitive function via mental and/or individualised aerobic training in healthy elderly subjects.Int J Sports Med. 2002; 23: 415-421
- Differential effects of single versus combined cognitive and physical training with older adults: The SimA study in a 5-year perspective.Eur J Ageing. 2006; 3: 179-192
- Concurrent strength and endurance training: From molecules to man.Med Sci Sports Exerc. 2006; 38: 1965-1970
Coe R. Effect size calculator: A guide to using the spreadsheet. Available at: http://www.cem.org/effect-size-calculator. Accessed October 17, 2014.
Registry Protocol No: X08-0064 (Australian and New Zealand Clinical Trials Registry; http://www.anzctr.org.au)
This study was funded by a National Health and Medical Research Council (NH&MRC) of Australia Dementia Research Grant, project grant ID No. 512672 from 2008-2011(https://www.nhmrc.gov.au). Additional funding for a research assistant position was sourced from the NHMRC Program Grant ID No. 568969, and the project was supported by the University of Sydney and University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MV was supported by a University of New South Wales Vice Chancellor's Fellowship and a NHMRC Clinical Career Development Fellowship (1004156). This work fulfilled a portion of the degree requirements for PhD for Nicola Gates and Chao Suo.
The authors declare no conflicts of interest.
MV has previously received speaking honoraria and research funding from Pfizer Neuroscience and The Brain Department Pty Ltd. He currently receives in-kind research support from BrainTrain Inc. for work unrelated to this report. HB has been an investigator for Pfizer, Novartis, Janssen, Lilly, Mediation, Sanofi and Servier; a sponsored speaker for Pfizer, Novartis, Janssen and Lundbeck; and is on advisory Boards for Pfizer, Novartis, Janssen, Lundbeck, Merck and Baxter. BB is a member of advisory boards and/or gave presentations for the following companies, for which he has received honoraria: AstraZeneca, Lundbeck, Pfizer, Servier, and Wyeth.